Structure | Chemical Name | CAS | MF |
|
1(6H)-Pyridazinecarboxylic acid, 6-ethynyl-, ethyl ester
|
157465-71-9
|
C9H10N2O2
|
|
1,1,2,2 - tetraMethyl - 1,2 - ethanediaMino - N,N' - bis(3,5 - di - tert - butylsalicylidene) - cobalt(II)
|
157472-96-3
|
C36H54CoN2O2
|
|
3-Hexanone, 2-chloro-1-hydroxy-
|
157474-45-8
|
C6H11ClO2
|
|
3-Hexanone, 4-chloro-1-hydroxy-
|
157474-49-2
|
C6H11ClO2
|
|
3-Hexanone, 4-chloro-6-hydroxy-
|
157474-50-5
|
C6H11ClO2
|
|
Cyclohexanone, 2-chloro-5-ethenyl-
|
157474-53-8
|
C8H11ClO
|
|
Cyclohexanone, 2-chloro-4-ethenyl-
|
157474-54-9
|
C8H11ClO
|
|
1-CHLORO-2-METHYL-2-HEPTANOL
|
157474-60-7
|
C8H17ClO
|
|
Oxirane, 2,2-dimethyl-3-(4-penten-1-yl)-
|
157474-64-1
|
C9H16O
|
|
Lagatide
|
157476-77-2
|
C33H58N10O9
|
|
Yubeinine
|
157478-01-8
|
C27H43NO3
|
|
Siloxanes and Silicones, di-Me, Me 3-(1-oxoeicosyl)oxypropyl
|
157479-50-0
|
|
|
Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol monoeicosanoate
|
157479-51-1
|
|
|
Siloxanes and Silicones, di-Me, 3-hydroxypropyl group-terminated, ethers with polyethylene-polypropylene glycol mono-Me ether
|
157479-55-5
|
|
|
Imidazo[1,2:2,3]pyrazolo[1,5-a]pyrimidine (9CI)
|
157479-86-2
|
C8H6N4
|
|
ectatomin
|
157481-64-6
|
|
|
DiMethyl Phosphate-13C2 SodiuM Salt
|
157487-95-1
|
C2H6NaO4P
|
|
(R)-MONOPHOS
|
157488-65-8
|
C22H18NO2P
|
|
(1-(Ethyl[1-(trimethylsilyl)vinyl]boryl)vinyl)(trimethyl)silane
|
157489-81-1
|
C12H27BSi2
|
|
N-(2,6-Dichlorophenyl)-4-MethylbenzaMide, 97%
|
157491-13-9
|
C14H11Cl2NO
|
|
4-Chloro-3-QuinolinesulfonylChloride
|
157494-40-1
|
C9H5Cl2NO2S
|
|
tert-Butyl 2-iodo-4-methoxyphenylcarbamate
|
157496-75-8
|
C12H16INO3
|
|
3-(PENTAFLUOROPHENYL)PROPYLDIMETHYLCHLOROSILANE
|
157499-19-9
|
C11H12ClF5Si
|
|
6-Maleimido-1-hexanol
|
157503-18-9
|
C10H15NO3
|
|
AC-ALA-GLU-TYR-TYR-ASN-LYS-GLN-TYR-LEU-GLU-GLN-THR-ARG-ALA-GLU-LEU-ASP-THR-NH2
|
157505-54-9
|
C100H150N26O35
|
|
Pyrazine, 3,6-diethoxy-1,2-dihydro-2-(1-methylethyl)-, (S)- (9CI)
|
157505-98-1
|
C11H20N2O2
|
|
Pyrazine, 3,6-diethoxy-1,2-dihydro-2-(1-methylethyl)-, (R)- (9CI)
|
157505-99-2
|
C11H20N2O2
|
|
FMOC-O-BENZYL-L-SERYL CHLORIDE
|
157506-72-4
|
C25H22ClNO4
|
|
transcription factor QM
|
157512-37-3
|
|
|
5-FLUORO-2-METHOXYCINNAMIC ACID
|
157518-45-1
|
C10H9FO3
|
|
(2R)-4-METHYL-2-[(S)-2,2-DIMETHYL-5-OXO-1,3-DIOXOLAN-4-YL]VALERIC ACID
|
157518-70-2
|
C11H18O5
|
|
1H-Benzimidazole,2-(1H-imidazol-4-yl)-(9CI)
|
157519-98-7
|
C10H8N4
|
|
1H-Benzimidazole,2-(2-methyl-1H-imidazol-4-yl)-(9CI)
|
157519-99-8
|
C11H10N4
|
|
1H-Benzimidazole,2-(5-methyl-1H-imidazol-4-yl)-(9CI)
|
157520-05-3
|
C11H10N4
|
|
2(S)-ACETYLTHIO-BENZENEPROPANOIC ACID N-CYCLOHEXYLCYCLOHEXANAMINE
|
157521-26-1
|
C23H35NO3S
|
|
Cyclopropanecarboxylic acid, 2-oxiranyl-, methyl ester, [1R-[1alpha,2alpha(S*)]]- (9CI)
|
157523-17-6
|
C7H10O3
|
|
diethyl benzylpiperazinomethylphosphonate
|
157524-19-1
|
C16H27N2O3P
|
|
diethyl benzylpiperazinomethylbenzylphosphonate
|
157524-21-5
|
C23H33N2O3P
|
|
4-(Chloroacetoxy)butyl acrylate
|
157525-13-8
|
C9H13ClO4
|
|
1H-Pyrrole-2-carboxaldehyde,3,5-dimethyl-4-propyl-(9CI)
|
157528-36-4
|
C10H15NO
|
|
(R)-1-Benzyl-3-pyrrolidinecarbonitrile
|
157528-56-8
|
C12H14N2
|
|
Coronarin D methyl ether
|
157528-81-9
|
C21H32O3
|
|
CULEKININ DEPOLARIZING PEPTIDE
|
157536-08-8
|
C40H50N12O9
|
|
murayalactone
|
157536-36-2
|
C18H16O5
|
|
D-myo-Inositol-1,4,5,6-tetraphosphate (sodium salt)
|
157542-47-7
|
C6H17NaO18P4
|
|
D-Proline, 4-fluoro-, methyl ester (9CI)
|
157543-42-5
|
C6H10FNO2
|
|
syntaxin
|
157546-56-0
|
|
|
2-(trimethylsilyl)ethyl 4-O-(3-O-(2-acetamido-2,4-dideoxy-xylohexopyranosyl)galactopyranosyl)galactopyranoside
|
157553-88-3
|
C25H47NO15Si
|
|
2-(trimethylsilyl)ethyl 4-O-(3-O-(2-deoxy-2-acetamido-glucopyranosyl)galactopyranosyl)galactopyranoside
|
157553-90-7
|
C25H47NO16Si
|
|
2-(trimethylsilyl)ethyl 4-O-(3-O-(galactopyranosyl)galactopyranosyl)galactopyranoside
|
157553-92-9
|
C23H44O16Si
|
|
N-(2-AMINO-4-BROMO-5-(TRIFLUOROMETHYL)PHENYL)ACETAMIDE
|
157554-73-9
|
C9H8BrF3N2O
|
|
N-(4-BROMO-5-(TRIFLUOROMETHYL)-2-NITROPHENYL)ACETAMIDE
|
157554-76-2
|
C9H6BrF3N2O3
|
|
1H-Imidazole-2,4-diamine,5-nitroso-(9CI)
|
157555-21-0
|
C3H5N5O
|
|
(S)-1-(tert-ButyldiMethylsilyloxy)-2-butanaMine
|
157555-74-3
|
C10H25NOSi
|
|
Isoxazole, 3-methyl-5-(2-methyl-5-oxazolyl)- (9CI)
|
157555-79-8
|
C8H8N2O2
|
|
Cyclopropanecarboxaldehyde, 2-(trimethylsilyl)-, cis- (9CI)
|
157556-34-8
|
C7H14OSi
|
|
Cyclopropanecarboxaldehyde, 2-(trimethylsilyl)-, trans- (9CI)
|
157556-35-9
|
C7H14OSi
|
|
3-Furancarboxylicacid,4-amino-2,5-dihydro-5-methoxy-5-methyl-2-oxo-,methylester(9CI)
|
157558-46-8
|
C8H11NO5
|
|
2-Propenamide, 2-cyano-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)-
|
157561-90-5
|
C11H8N4O
|
|
2-Propenamide, 2-cyano-N-phenyl-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)-
|
157561-97-2
|
C17H12N4O
|
|
Propanedinitrile, 2-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-
|
157561-99-4
|
C11H6N4
|
|
2-Pyridinecarboxylicacid,3-amino-,trimethylsilylester(9CI)
|
157562-24-8
|
C9H14N2O2Si
|
|
Benzaldehyde, 2-(1-hydroxyethyl)-, (S)- (9CI)
|
157563-46-7
|
C9H10O2
|
|
Carbamic acid, (3-amino-2-methylphenyl)-, methyl ester (9CI)
|
157563-54-7
|
C9H12N2O2
|
|
L-Norleucine, 5-amino-6-fluoro-, threo- (9CI)
|
157563-59-2
|
C6H13FN2O2
|
|
EXP 597
|
157566-60-4
|
C42H44FN3O7S
|
|
homothallin II
|
157566-63-7
|
C8H7NO2
|
|
Poly(oxy-1,2-ethandiyl), alpha-(2-methyl-1-oxo-2-propenyl)-omega-(isotridecyloxy), mittlerer EO 20 mol
|
157567-90-3
|
|
|
vibrioferrin
|
157568-17-7
|
C16H22N2O12
|
|
6'-N-ACETYLNEURAMIN-LACTOSE SODIUM SALT
|
157574-76-0
|
C23H40NNaO19
|
|
cytochrome P-450 4D2
|
157574-86-2
|
|
|
Acid Black 234
|
157577-99-6
|
C34H29N10NaO9S3
|
|
Benzene, 1-(3-butenyl)-4-(1-methylethyl)- (9CI)
|
157581-06-1
|
C13H18
|
|
4-(2-BIPHENYL)-1-BUTENE
|
157581-09-4
|
C16H16
|
|
1H-Indole-6,7-dione,3,4-dimethyl-(9CI)
|
157583-30-7
|
C10H9NO2
|
|
3-ETHYL-2-(2-HYDROXY-1-PROPENYL)BENZOTHIAZOLIUM CHLORIDE
|
157584-19-5
|
C12H14ClNOS
|
|
2,3-Difluoro-4-octylbenzoic acid
|
157584-89-9
|
C15H20F2O2
|
|
5H-Benzocycloheptene,2-fluoro-6,7-dihydro-(9CI)
|
157585-00-7
|
C11H11F
|
|
2,6-BIS(2',6'-DIMETHYL-1'-NAPHTHOYL)NAPHTHALENE
|
157585-49-4
|
C36H28O2
|
|
1H-Benzimidazol-4-ol,1-butyl-(9CI)
|
157587-56-9
|
C11H14N2O
|
|
1H-Benzimidazol-5-ol,6-methoxy-(9CI)
|
157587-57-0
|
C8H8N2O2
|
|
1H-Benzimidazole-4,7-diol,1-methyl-(9CI)
|
157587-58-1
|
C8H8N2O2
|
|
1,2-Dibenzofurandione, 6,7,8,9-tetrahydro- (9CI)
|
157589-00-9
|
C12H10O3
|
|
1,2,4,5-Tetroxane,3,6-dichloro-,trans-(9CI)
|
157589-97-4
|
C2H2Cl2O4
|
|
2-CHLORO-4,5-DIAMINOBENZOTRIFLUORIDE
|
157590-59-5
|
C7H6ClF3N2
|
|
4-BROMO-5-(TRIFLUOROMETHYL)BENZENE-1,2-DIAMINE
|
157590-60-8
|
C7H6BrF3N2
|
|
1H-BENZOTRIAZOLE, 5-(TRIFLUOROMETHOXY)-
|
157590-69-7
|
C7H4F3N3O
|
|
2-Propen-1-one,1-(2-pyridinyl)-(9CI)
|
157592-40-0
|
C8H7NO
|
|
CYCLOPENTYL 2-PYRIDYL KETONE
|
157592-43-3
|
C11H13NO
|
|
2-(4-T-BUTYLBENZOYL)PYRIDINE
|
157592-45-5
|
C16H17NO
|
|
2-Pyrrolidineaceticacid,-alpha-,3,4-trihydroxy-,[2S-[2-alpha-(S*),3-alpha-,4-alpha-]]-(9CI)
|
157598-76-0
|
C6H11NO5
|
|
2H-Furo[3,2-b]pyrrol-2-one,hexahydro-3,6-dihydroxy-,[3R-(3-alpha-,3a-alpha-,6-bta-,6a-alpha-)]-(9CI)
|
157598-77-1
|
C6H9NO4
|
|
D-Allonamide, 2,3:5,6-dianhydro- (9CI)
|
157598-79-3
|
C6H9NO4
|
|
1,4,7,10-Tetrakis(aminocarbonylmethyl)-1,4,7,10-tetraazacyclododecane
|
157599-02-5
|
C16H32N8O4
|
|
DISODIUM (2S,3R)-2-HYDROXY-3-ISOBUTYLSUCCINATE
|
157604-22-3
|
C8H14O5
|
|
3-(1,1-DIMETHYLETHYL)-4-METHYL-(R,S)-2,2-DIMETHYL-3,4-OXAZOLIDINEDICARBOXYLATE
|
157604-46-1
|
C12H21NO5
|
|
(S)-1-[2-[TRIS(4-METHOXYPHENYL)METHOXY]ETHYL]-3-PIPERIDINECARBOXYLIC ACID
|
157604-55-2
|
C30H35NO6
|
|
alatrofloxacin
|
157605-25-9
|
C27H29F3N6O8S
|
|
CECROPIN A (1-7)-MELITTIN A (2-9) AMIDE
|
157606-25-2
|
C89H152N22O15
|
|
ANTHRYLMETHYL OKADAATE
|
157606-35-4
|
C59H78O13
|